GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Valneva SE (XBUL:AYJ) » Definitions » Days Sales Outstanding

Valneva SE (XBUL:AYJ) Days Sales Outstanding : 59.70 (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Valneva SE Days Sales Outstanding?

Valneva SE's average Accounts Receivable for the three months ended in Sep. 2024 was лв61.8 Mil. Valneva SE's Revenue for the three months ended in Sep. 2024 was лв94.5 Mil. Hence, Valneva SE's Days Sales Outstanding for the three months ended in Sep. 2024 was 59.70.

The historical rank and industry rank for Valneva SE's Days Sales Outstanding or its related term are showing as below:

XBUL:AYJ' s Days Sales Outstanding Range Over the Past 10 Years
Min: 33.16   Med: 56.26   Max: 80.19
Current: 80.19

During the past 13 years, Valneva SE's highest Days Sales Outstanding was 80.19. The lowest was 33.16. And the median was 56.26.

XBUL:AYJ's Days Sales Outstanding is ranked worse than
55.01% of 869 companies
in the Biotechnology industry
Industry Median: 71.77 vs XBUL:AYJ: 80.19

Valneva SE's Days Sales Outstanding declined from Sep. 2023 (94.11) to Sep. 2024 (59.70).


Valneva SE Days Sales Outstanding Historical Data

The historical data trend for Valneva SE's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valneva SE Days Sales Outstanding Chart

Valneva SE Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 51.42 68.12 33.93 35.79 77.02

Valneva SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 94.11 92.61 96.21 69.61 59.70

Competitive Comparison of Valneva SE's Days Sales Outstanding

For the Biotechnology subindustry, Valneva SE's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valneva SE's Days Sales Outstanding Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Valneva SE's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Valneva SE's Days Sales Outstanding falls into.



Valneva SE Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Valneva SE's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (47.081 + 84.407) / 2 ) / 311.547*365
=65.744 / 311.547*365
=77.02

Valneva SE's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

Days Sales Outstanding (Q: Sep. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2024 ) + Accounts Receivable (A: Sep. 2024 )) / count ) / Revenue (A: Sep. 2024 )*Days in Period
=( (61.058 + 62.625) / 2 ) / 94.526*365 / 4
=61.8415 / 94.526*365 / 4
=59.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Valneva SE  (XBUL:AYJ) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Valneva SE Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Valneva SE's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Valneva SE Business Description

Address
6 Rue Alain Bombard, Saint-Herblain, FRA, 44800
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.

Valneva SE Headlines

No Headlines